Limited impact of short-term disruptions, growth momentum to continue in FY 23
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
Tamper evident caps with incorporated RFID technology offer a significant reduction in RFID implementation costs
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
By connecting a leading LongBio VC to the DeSci (decentralized science) movement, this partnership is a major milestone for the greater decentralized ecosystem
ABDM is a digital framework that will connect patients, doctors and other healthcare stakeholders nationwide to facilitate safe and secure movement of health information
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
It is the first monoclonal antibody drug for use in any animal species
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference
Subscribe To Our Newsletter & Stay Updated